These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4536441)

  • 1. The natural history and treatment of mesangiocapillary glomerulonephritis.
    Kincaid-Smith P
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():591-609. PubMed ID: 4536441
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe fibrin and crescent glomerulonephritis: clinical and morphological aspects of 33 patients.
    Mathew TH; Kincaid-Smith P
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):727-34. PubMed ID: 4803314
    [No Abstract]   [Full Text] [Related]  

  • 3. Are anticoagulants beneficial in the treatment of rapidly progressive glomerulonephritis?
    Cameron JS
    Proc Eur Dial Transplant Assoc; 1973; 10(0):57-90. PubMed ID: 4606240
    [No Abstract]   [Full Text] [Related]  

  • 4. Glomerulonephritis in Henoch-Schölein syndrome.
    Kalowski S; Kincaid-Smith P
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1123-37. PubMed ID: 4803307
    [No Abstract]   [Full Text] [Related]  

  • 5. The natural history and treatment of membranous glomerulonephritis.
    Laver MC; Kincaid-Smith P
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():461-72. PubMed ID: 4536438
    [No Abstract]   [Full Text] [Related]  

  • 6. Membranous nephropathy.
    Churg J; Ehrenreich T
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():443-8. PubMed ID: 4536436
    [No Abstract]   [Full Text] [Related]  

  • 7. Morphological and clinical long-term follow-up study of adult patients with type I and type III diffuse mesangiocapillary (membranoproliferative) glomerulonephritis.
    Knotková V; Stejskalová A; Stejskal J; Nĕmecek K
    Acta Univ Carol Med (Praha); 1987; 33(5-6):477-526. PubMed ID: 3453012
    [No Abstract]   [Full Text] [Related]  

  • 8. Focal necrotizing glomerulonephritis.
    Johnson JR; McGovern VJ
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):749-68. PubMed ID: 4803316
    [No Abstract]   [Full Text] [Related]  

  • 9. The treatment of chronic mesangiocapillary (membranoproliferative) glomerulonephritis with impaired renal function.
    Kincaid-Smith P
    Med J Aust; 1972 Sep; 2(11):587-92. PubMed ID: 5082784
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of combined immunosuppressive anticoagulant and antiplatelet therapy of the course of chronic mesangial-proliferative glomerulonephritis.
    Matousovic K; Matl I; Zabka J; Zástava V; Rossmann P; Prát V
    Czech Med; 1985; 8(3):151-7. PubMed ID: 3932033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lupus nephritis: clinical course in relation to treatment.
    Nanra RS; Kincaid-Smith P
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1193-210. PubMed ID: 4803309
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinicopathologic predictors of death and ESRD in patients with pauci-immune necrotizing glomerulonephritis.
    Kapitsinou PP; Ioannidis JP; Boletis JN; Sotsiou F; Nakopoulou L; Daphnis E; Moutsopoulos HM
    Am J Kidney Dis; 2003 Jan; 41(1):29-37. PubMed ID: 12500219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of poststreptococcal glomerulonephritis.
    Baldwin DS; Gluck MC; Schacht RG; Moussalli A; Gallo GR
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():327-43. PubMed ID: 4536430
    [No Abstract]   [Full Text] [Related]  

  • 14. Lobular glomerulonephritis and membranoproliferative glomerulonephritis: a clinical and pathologic study based on renal biopsies.
    Mandalenakis N; Mendoza N; Pirani CL; Pollak VE
    Medicine (Baltimore); 1971 Jul; 50(4):319-55. PubMed ID: 5143573
    [No Abstract]   [Full Text] [Related]  

  • 15. Glomerulonephritis with fibrin and crescent formation.
    Lawrence JR
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):739-48. PubMed ID: 4803315
    [No Abstract]   [Full Text] [Related]  

  • 16. Myeloid-related protein 8 expression on macrophages is a useful prognostic marker for renal dysfunction in children with MPGN type 1.
    Kawasaki Y; Hosoya M; Takahashi A; Isome M; Tanji M; Suzuki H
    Am J Kidney Dis; 2005 Mar; 45(3):510-8. PubMed ID: 15754273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary mesangiocapillary glomerulonephritis].
    Diadyk AI; Dikshteĭn EA; Vasilenko IV; Siniachenko OV; Kobets VG
    Klin Med (Mosk); 1987 Apr; 65(4):56-60. PubMed ID: 3599858
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of clearance studies in lupus nephritis.
    Rosenbaum JL; Akhtar M; Kramer MS; Raja RM; Manchanda R; Lazaro N
    Clin Nephrol; 1974; 2(2):47-51. PubMed ID: 4830511
    [No Abstract]   [Full Text] [Related]  

  • 19. Rapidly progressive glomerulonephritis treated with anticoagulants.
    Arieff AI; Pinggera WF
    Arch Intern Med; 1972 Jan; 129(1):77-84. PubMed ID: 4550298
    [No Abstract]   [Full Text] [Related]  

  • 20. Natural history of oliguric glomerulonephritis.
    Schreiner GE; Rakowski TA; Argy WP; Marc-Aurele J; Maher JF; Bauer H
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):711-25. PubMed ID: 4803313
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.